...

CCO Slideset

A Call to Action: Preventing Bone Loss and Skeletal-Related Events in Patients With Prostate Cancer: Highlights From the Symposium

Source: A Call to Action: Preventing Bone Loss and Skeletal-Related Events in Patients With Prostate Cancer: Highlights From the Symposium

A Call to Action: Preventing Bone Loss and Skeletal-Related Events in Patients With Prostate Cancer: Highlights From the Symposium


Program Director: Matthew R. Smith, MD, PhD

Faculty: Celestia S. Higano, MD, FACP, Gregory R. Mundy, MD, Joel Byron Nelson, MD

CREDIT INFORMATION

Release Date: June 15, 2009

Expiration Date: June 14, 2010


Physicians: maximum of 0.75 AMA PRA Category 1 Credits™

Status: The activity is not currently available for credit.

Begin the CCO Slideset

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe the pathophysiology of treatment-related bone loss and bone metastases in patients with prostate cancer
  • Discuss current and novel treatment approaches for patients with prostate cancer who experience treatment-related bone loss and skeletal-related events
  • Summarize clinical trial data on the use of specific therapeutic agents to prevent bone metastases in prostate cancer patients
  • Cite novel molecular targets under investigation for the treatment of skeletal-related events in patients with prostate cancer

Topics covered include:

  • The Bone Microenvironment and the Prostate Cancer Patient: Key Concepts
  • Treatment-Related Bone Loss: Risk Assessment and Current and Emerging Approaches to Therapy
  • Prevention of Metastatic Disease: Are New Options on the Horizon?
  • Evolving Evidence for the Treatment of Bone Metastases in Prostate Cancer
Disclaimer: The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Contact Info

Educational grant provided by:

Educational grants support only the CME-certified components of this program.